Blood thinners and diabetes medicine could become less expensive, as the Biden administration included them on the list of the first 10 drugs up for price negotiations with Medicare. To understand how this could impact American small businesses, NTD spoke with Javier Palomarez, founder and CEO of the U.S. Hispanic Business Council.
Drug Price Negotiations Are a ‘Big Win’ for Small Businesses: CEO
By Chris Beers
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.